Verastem Reports Year-End 2012 Financial Results

"Verastem achieved important milestones in our mission to bring new therapies targeting cancer stem cells to patients during 2012," said Christoph Westphal, M.D., Ph.D., Chairman and Chief Executive Officer of Verastem.

http://eon.businesswire.com/news/eon/20130327005349/en/Verastem-Reports-Year-End-2012-Financial-Results